Press Releases
MONMOUTH JUNCTION, N.J., Sept. 25, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its
Read more...25 September 2019
WESTON, Fla., Sept. 25, 2019 /PRNewswire/ -- ZyVersa Therapeutics, Inc., (ZyVersa) a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce that CEOCFO Magazine published an in-depth interview with Co-founder, CEO, and President, Stephen C. Glover
Read more...25 September 2019
HANGZHOU, China, Sept. 25, 2019 /PRNewswire/ -- The preclinical results of AB-106 (original code: DS-6051b), an investigational next generation ROS1/NTRK dual inhibitor exclusively in-licensed by AnHeart Therapeutics, a wholly-owned subsidiary of Baoyuan Biopharmaceuticals Technology (Hangzhou) Co., Ltd. ("Baoyuan") from Daiichi Sank
Read more...25 September 2019
WOBURN, Mass., Sept. 25, 2019 /PRNewswire/ -- Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, an
Read more...25 September 2019
NEW YORK, Sept. 25, 2019 /PRNewswire/ -- The Rockefeller Foundation and leading global health partners announced today a $100 million Precision Public Health initiative to empower community health systems and frontline health workers with the latest data science innovations, including more accurate and precise decision-making tools ba
Read more...25 September 2019
ABINGDON, England, Sept. 25, 2019 /PRNewswire/ -- Penlon Ltd, UK-based manufacturer of Anaesthesia equipment, is proud to announce the launch of the new Sigma EVA, an advanced electronic vaporizer specifically designed to provide a better way to deliver of Desflurane. Penlon will be one of a very small number of companies to have developed and launched a Vaporizer for Desflurane.
Read more...25 September 2019
LUND, Sweden, Sept. 25, 2019 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced that a date for a follow- up meeting with the U.S. Food and Drug Administration (FDA) has now been confirmed. The meeting will take place on November 20th, 2019.At the upcoming
Read more...24 September 2019
POMONA, Calif., Sept. 24, 2019 /PRNewswire/ -- Teamsters Joint Council 42 and Joint Council 7, representing a combined 350,000 workers and retirees in California, voted to support an unfair labor practices strike beginning Oct. 14 that affects more than 80,000 workers at Kaiser Permanente in
Read more...24 September 2019
SAN DIEGO, Sept. 24, 2019 /PRNewswire/ -- Agragene Inc. today announced that it has acquired an exclusive, worldwide license to Precision-Guided Sterile Insect TechnologyTM from the University of California. Agragene uses this technology to create environmentally responsible insect pest control products for growers. With insect
Read more...24 September 2019
SILVER SPRING, Md., Sept. 24, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration is alerting health care professionals and patients of a
Read more...